Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome
ISRCTN ISRCTN52577337
ClinicalTrials.gov identifier
Public title Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis The effects of a supplementary Arginine-Vasopressin (AVP) infusion on microcirculation in advanced vasodilatory shock and postoperative multiple organ dysfunction syndrome are unknown.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Austria
Disease/condition/study domain Severe multiple organ dysfunction syndrome
Participants - inclusion criteria Critically ill patients suffering of severe multiple organ dysfunction syndrome after cardiac or major surgery with a mean arterial blood pressure less than 65 mmHg despite adequate volume resuscitation, and Norepinephrine (NE) requirements greater than 0.5 µg/kg/min.
Participants - exclusion criteria Patients with arterial vascular occlusive disease or insulin-dependent diabetes mellitus.
Anticipated start date 01/01/2004
Anticipated end date 31/12/2004
Status of trial Completed
Patient information material
Target number of participants 18
Interventions NE plus supplementary AVP (Pitressin®; Pfizer, Karlsruhe, Germany) infused at a continuous rate of 4 IU/hour versus NE alone.
Primary outcome measure(s) Differences in the area under the concentration-time Area Under Curve (AUC) of the Doppler signal and the reactive hyperemic response to forearm ischaemia between AVP/NE and NE patients.
Secondary outcome measure(s) Differences in the oscillation frequency of the Doppler signal between groups.
Sources of funding Innsbruck Medical University (Austria)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=16542484
Contact name Dr  Guenter  Luckner
  Address Anichstrasse 35
  City/town Innsbruck
  Zip/Postcode 6020
  Country Austria
Sponsor Innsbruck Medical University (Austria)
  Address Christoph-Probst-Platz
Innrain 52
  City/town Innsbruck
  Zip/Postcode 6020
  Country Austria
  Sponsor website: http://www.i-med.ac.at
Date applied 14/10/2005
Last edited 17/09/2007
Date ISRCTN assigned 21/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central